The latest evidence on the impact of fatty liver on liver-related outcomes and mortality in chronic hepatitis B

키워드

참고문헌 (16)

1. Polaris Observatory Collaborators, "Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016 : a modelling study", Lancet Gastroenterol Hepatol, 3, pp.383~403 (2018)
2. Younossi ZM, "Global epidemiology of nonalcoholic fatty liver disease-Metaanalytic assessment of prevalence, incidence, and outcomes", Hepatology, 64, pp.73~84 (2016)
3. Huang J, "The impact of hepatitis B virus infection status on the prevalence of nonalcoholic fatty liver disease : A population-based study", J Med Virol, 92, pp.1191~1197 (2020)
4. Kim MN, "Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liver", Aliment Pharmacol Ther, 55, pp.97~107 (2022)
5. Mak LY, "Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection", Hepatol Int, 15, pp.901~911 (2021)
6. Yu Jun Wong, "Impact of fatty liver on long-term outcomes in chronic hepatitis B: a systematic review and matched analysis of individual patient data meta-analysis", Clinical and Molecular Hepatology, 29(3), pp.705~720 (2023), 대한간학회
7. Mao X, "Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance : A systematic review and meta-analysis", Hepatology, 77, pp.1735~1745 (2023)
8. Li J, "Association between fatty liver and cirrhosis, hepatocellular carcinoma, and hepatitis B surface antigen seroclearance in chronic hepatitis B", J Infect Dis, 224, pp.294~302 (2021)
9. Yu MW, "Hepatic steatosis and development of type 2 diabetes : Impact of chronic hepatitis B and viral specific factors", J Formos Med Assoc, 121, pp.1478~1487 (2022)
10. Wong GL, "Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B--a prospective cohort study with paired transient elastography examinations", Aliment Pharmacol Ther, 39, pp.883~893 (2014)
11. Zhang X, "Animal models for the study of hepatitis B virus pathobiology and immunity : Past, present, and future", Front Microbiol, 12, pp.715450~ (2021)
12. Seto WK, "Bodymass index is associated with fibrosis regression during longterm nucleoside analogue therapy in chronic hepatitis B", Aliment Pharmacol Ther, 44, pp.1071~1079 (2016)
13. Oh JH, "Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy", Hepatol Int, 15, pp.892~900 (2021)
14. Hui RWH, "Inverse relationship between hepatic steatosis and hepatitis B viremia : Results of a large case-control study", J Viral Hepat, 25, pp.97~104 (2018)
15. Jeng WJ, "Hepatitis B", Lancet, 401, pp.1039~1052 (2023)
16. Michael H. Le, "Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach", Clinical and Molecular Hepatology, 28(4), pp.841~850 (2022), 대한간학회

관련 논문AI추천